4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 1 Study of Oral MG001Chemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorderNot yet recruitingPhase 12026-06-16NCT07204171
Study of a Novel Type 3 Oral Poliomyelitis Vaccine in PanamaInfections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious diseaseRecruitingPhase 22026-05-11NCT05654467
Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines EvaluationInfections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious diseaseRecruitingPhase 22026-01-09NCT06895486
Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic FeverBunyaviridae infectious disease, Crimean-Congo hemorrhagic fever, Infections, RNA Virus Infections, arbovirus infection, tick-borne infectious disease, vector-borne disease, viral hemorrhagic fever, viral infectious diseaseRecruitingPhase 12025-07-28NCT06799013